Institutional Ownership
Summit Therapeutics Inc
CUSIP 86627T108COMSMMTQ1 2026
Institutional Holders
217
13F filers
Shares Held
106.69M
Aggregate institutional
Institutional Value
$1.86B
Q1 2026
Net New Holders
+18
52 new · 34 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions52
Increased84
Decreased49
Sold out34
Institutional Holders
217 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Baker Bros. Advisors LP | 36.39M | $689.97M | 0 | Held |
| 2 | Fmr LLC | 10.85M | $205.78M | −2.51M | Reduced |
| 3 | Blackrock, Inc. | 9.65M | $183.04M | +291.8K | Added |
| 4 | State Street Corp | 7.03M | $133.25M | +391.8K | Added |
| 5 | Ubs Group AG | 3.68M | $69.78M | +2.81M | Added |
| 6 | Geode Capital Management, LLC | 3.32M | $62.89M | +168.4K | Added |
| 7 | D. E. Shaw & Co., Inc. | 2.24M | $42.51M | +1.83M | Added |
| 8 | Morgan Stanley | 1.65M | $31.30M | +724.0K | Added |
| 9 | Apeiron Capital Ltd | 1.31M | $24.82M | −100 | Reduced |
| 10 | Pictet Asset Management Holding SA | 1.32M | $23.96M | −60.6K | Reduced |
207 more institutional holders on Premium
See every fund holding Summit Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders